| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Finger Injuries | 9 | 2019 | 139 | 2.740 |
Why?
|
| Amputation, Traumatic | 6 | 2021 | 123 | 2.530 |
Why?
|
| Surgery, Plastic | 8 | 2023 | 624 | 2.400 |
Why?
|
| Glucosephosphate Dehydrogenase | 8 | 2014 | 207 | 1.760 |
Why?
|
| Congresses as Topic | 4 | 2019 | 763 | 1.420 |
Why?
|
| Microsurgery | 11 | 2021 | 785 | 1.400 |
Why?
|
| Skin Transplantation | 4 | 2018 | 1074 | 1.320 |
Why?
|
| Emergency Service, Hospital | 27 | 2024 | 7658 | 1.210 |
Why?
|
| Transplants | 2 | 2018 | 209 | 1.100 |
Why?
|
| Replantation | 5 | 2021 | 148 | 1.100 |
Why?
|
| Surgical Flaps | 9 | 2017 | 1629 | 1.060 |
Why?
|
| Glucosephosphate Dehydrogenase Deficiency | 9 | 2014 | 89 | 0.810 |
Why?
|
| Patient Discharge | 4 | 2022 | 3317 | 0.790 |
Why?
|
| Brain Ischemia | 6 | 2022 | 3264 | 0.790 |
Why?
|
| Syncope | 5 | 2016 | 429 | 0.770 |
Why?
|
| Tobacco Use Cessation | 1 | 2021 | 95 | 0.720 |
Why?
|
| Reperfusion | 1 | 2019 | 283 | 0.650 |
Why?
|
| Transplantation, Heterotopic | 3 | 2011 | 175 | 0.630 |
Why?
|
| Nerve Regeneration | 8 | 2004 | 788 | 0.580 |
Why?
|
| Peripheral Nerves | 5 | 2009 | 466 | 0.550 |
Why?
|
| Patients | 1 | 2023 | 899 | 0.550 |
Why?
|
| Emergency Medicine | 5 | 2018 | 1205 | 0.540 |
Why?
|
| Nails | 1 | 2017 | 292 | 0.540 |
Why?
|
| Hypersensitivity | 1 | 2024 | 1102 | 0.500 |
Why?
|
| Thumb | 4 | 2014 | 227 | 0.500 |
Why?
|
| Ganglion Cysts | 1 | 2014 | 28 | 0.490 |
Why?
|
| Stroke | 9 | 2022 | 9975 | 0.480 |
Why?
|
| Disability Evaluation | 4 | 2021 | 1828 | 0.480 |
Why?
|
| Radial Neuropathy | 1 | 2014 | 26 | 0.480 |
Why?
|
| Carpal Tunnel Syndrome | 2 | 2014 | 300 | 0.470 |
Why?
|
| Trigger Finger Disorder | 1 | 2014 | 52 | 0.470 |
Why?
|
| Veins | 8 | 2003 | 770 | 0.460 |
Why?
|
| Tissue Survival | 1 | 2013 | 118 | 0.450 |
Why?
|
| Efficiency | 4 | 2021 | 462 | 0.430 |
Why?
|
| Bone Transplantation | 1 | 2017 | 897 | 0.430 |
Why?
|
| Stents | 5 | 2017 | 3280 | 0.430 |
Why?
|
| Telemetry | 1 | 2014 | 208 | 0.430 |
Why?
|
| Nerve Compression Syndromes | 1 | 2014 | 160 | 0.430 |
Why?
|
| Motor Cortex | 1 | 2020 | 986 | 0.420 |
Why?
|
| NADP | 1 | 2013 | 226 | 0.420 |
Why?
|
| Hand | 5 | 2023 | 884 | 0.410 |
Why?
|
| Lidocaine | 2 | 2014 | 544 | 0.400 |
Why?
|
| Thrombin | 1 | 2014 | 598 | 0.400 |
Why?
|
| Hemostatics | 1 | 2014 | 229 | 0.400 |
Why?
|
| Adipose Tissue | 3 | 2018 | 3280 | 0.400 |
Why?
|
| Estradiol | 2 | 2013 | 2017 | 0.400 |
Why?
|
| Toe Joint | 1 | 2011 | 19 | 0.400 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2014 | 585 | 0.390 |
Why?
|
| Ear | 3 | 2006 | 172 | 0.380 |
Why?
|
| China | 6 | 2021 | 2243 | 0.380 |
Why?
|
| Clinical Clerkship | 1 | 2016 | 532 | 0.370 |
Why?
|
| Transcranial Magnetic Stimulation | 1 | 2020 | 1433 | 0.370 |
Why?
|
| Troponin | 1 | 2014 | 524 | 0.360 |
Why?
|
| Motor Activity | 2 | 2020 | 2714 | 0.360 |
Why?
|
| Sciatic Nerve | 6 | 2004 | 607 | 0.350 |
Why?
|
| Graft Survival | 5 | 2018 | 3734 | 0.350 |
Why?
|
| Neuroma | 3 | 2000 | 103 | 0.340 |
Why?
|
| Educational Measurement | 1 | 2016 | 1210 | 0.340 |
Why?
|
| Joints | 1 | 2011 | 326 | 0.340 |
Why?
|
| Ear, External | 4 | 1993 | 161 | 0.340 |
Why?
|
| Germ Cells | 1 | 2013 | 629 | 0.340 |
Why?
|
| Tissue Plasminogen Activator | 3 | 2021 | 1263 | 0.310 |
Why?
|
| Humans | 103 | 2024 | 743811 | 0.300 |
Why?
|
| Patient Selection | 2 | 2020 | 4210 | 0.300 |
Why?
|
| Anesthetics, Local | 1 | 2014 | 985 | 0.300 |
Why?
|
| Hydrogen Peroxide | 6 | 2013 | 730 | 0.290 |
Why?
|
| Hemin | 2 | 1997 | 50 | 0.290 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2013 | 852 | 0.280 |
Why?
|
| Efficiency, Organizational | 3 | 2021 | 695 | 0.280 |
Why?
|
| Erythrocyte Membrane | 4 | 1997 | 442 | 0.270 |
Why?
|
| Tissue Transplantation | 1 | 2006 | 129 | 0.270 |
Why?
|
| Patient Admission | 3 | 2023 | 1380 | 0.260 |
Why?
|
| Autophagy | 1 | 2013 | 1296 | 0.260 |
Why?
|
| Oxidative Stress | 2 | 2013 | 3082 | 0.260 |
Why?
|
| Transplantation, Autologous | 7 | 2011 | 2123 | 0.240 |
Why?
|
| Patient Transfer | 2 | 2024 | 762 | 0.240 |
Why?
|
| Pain, Postoperative | 1 | 2014 | 1642 | 0.240 |
Why?
|
| Image Cytometry | 1 | 2004 | 54 | 0.230 |
Why?
|
| Societies, Medical | 1 | 2016 | 3740 | 0.230 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 2004 | 230 | 0.230 |
Why?
|
| Hypertension | 2 | 2022 | 8480 | 0.220 |
Why?
|
| Schwann Cells | 1 | 2003 | 196 | 0.210 |
Why?
|
| Tendons | 4 | 2017 | 548 | 0.210 |
Why?
|
| Body Fluids | 1 | 2023 | 319 | 0.210 |
Why?
|
| Male | 58 | 2023 | 349776 | 0.200 |
Why?
|
| Length of Stay | 4 | 2023 | 6311 | 0.200 |
Why?
|
| Skin Aging | 1 | 2023 | 127 | 0.200 |
Why?
|
| Erythrocytes | 6 | 2001 | 2455 | 0.200 |
Why?
|
| France | 1 | 2023 | 517 | 0.200 |
Why?
|
| Echocardiography | 1 | 2014 | 5096 | 0.200 |
Why?
|
| Ambulances | 1 | 2021 | 95 | 0.190 |
Why?
|
| Mobile Health Units | 1 | 2021 | 80 | 0.190 |
Why?
|
| Neutrophils | 1 | 2013 | 3718 | 0.190 |
Why?
|
| Rats | 19 | 2006 | 24250 | 0.180 |
Why?
|
| Angioplasty | 2 | 2013 | 364 | 0.180 |
Why?
|
| Internship and Residency | 5 | 2018 | 5787 | 0.180 |
Why?
|
| Amputation Stumps | 1 | 2000 | 39 | 0.180 |
Why?
|
| Erythrocyte Deformability | 3 | 1996 | 56 | 0.180 |
Why?
|
| Peripheral Nervous System Diseases | 2 | 2004 | 685 | 0.180 |
Why?
|
| Cerebral Hemorrhage | 2 | 2010 | 2647 | 0.180 |
Why?
|
| Axons | 4 | 2006 | 1685 | 0.180 |
Why?
|
| Female | 46 | 2023 | 380020 | 0.180 |
Why?
|
| Prone Position | 1 | 2020 | 194 | 0.180 |
Why?
|
| Nerve Degeneration | 1 | 2004 | 748 | 0.170 |
Why?
|
| Electrophoresis, Capillary | 1 | 1999 | 64 | 0.170 |
Why?
|
| Endarterectomy, Carotid | 2 | 2017 | 546 | 0.170 |
Why?
|
| Skull | 2 | 2001 | 812 | 0.170 |
Why?
|
| Texas | 1 | 2020 | 390 | 0.170 |
Why?
|
| Aqueous Humor | 1 | 1999 | 161 | 0.170 |
Why?
|
| Uveitis, Anterior | 1 | 1999 | 101 | 0.170 |
Why?
|
| Retrospective Studies | 16 | 2024 | 77410 | 0.170 |
Why?
|
| Recovery of Function | 3 | 2020 | 2922 | 0.160 |
Why?
|
| Fingers | 3 | 1993 | 513 | 0.160 |
Why?
|
| Gynecomastia | 1 | 1999 | 87 | 0.160 |
Why?
|
| Absorbable Implants | 1 | 2001 | 336 | 0.160 |
Why?
|
| Physicians | 3 | 2023 | 4569 | 0.160 |
Why?
|
| Lipid Peroxidation | 2 | 1997 | 270 | 0.160 |
Why?
|
| Ovary | 1 | 2003 | 980 | 0.160 |
Why?
|
| Sulfhydryl Compounds | 2 | 1997 | 298 | 0.160 |
Why?
|
| Ascorbic Acid | 2 | 1999 | 650 | 0.160 |
Why?
|
| Bone Plates | 2 | 2001 | 468 | 0.160 |
Why?
|
| Patient Positioning | 1 | 2020 | 324 | 0.160 |
Why?
|
| Bone Regeneration | 1 | 2001 | 420 | 0.160 |
Why?
|
| Oximetry | 1 | 2021 | 471 | 0.150 |
Why?
|
| Glutathione | 3 | 1997 | 590 | 0.150 |
Why?
|
| Plasminogen Activators | 1 | 1998 | 209 | 0.150 |
Why?
|
| Superoxides | 1 | 1998 | 387 | 0.150 |
Why?
|
| Cyclosporine | 2 | 2006 | 788 | 0.150 |
Why?
|
| Reactive Oxygen Species | 2 | 2013 | 2077 | 0.150 |
Why?
|
| Skin | 3 | 2023 | 4372 | 0.150 |
Why?
|
| Splints | 1 | 2017 | 110 | 0.150 |
Why?
|
| Apoptosis | 1 | 2013 | 9718 | 0.140 |
Why?
|
| Granulocytes | 1 | 1998 | 548 | 0.140 |
Why?
|
| Tetradecanoylphorbol Acetate | 2 | 2013 | 821 | 0.140 |
Why?
|
| Prenatal Diagnosis | 1 | 2004 | 1237 | 0.140 |
Why?
|
| Femoral Vein | 3 | 1988 | 159 | 0.140 |
Why?
|
| Chi-Square Distribution | 1 | 2023 | 3503 | 0.140 |
Why?
|
| Lacerations | 1 | 2017 | 143 | 0.140 |
Why?
|
| Triage | 1 | 2023 | 977 | 0.130 |
Why?
|
| Treatment Outcome | 11 | 2020 | 63042 | 0.130 |
Why?
|
| Down Syndrome | 1 | 2004 | 880 | 0.130 |
Why?
|
| Medicine | 1 | 2024 | 945 | 0.130 |
Why?
|
| Radiodermatitis | 1 | 1995 | 60 | 0.130 |
Why?
|
| Burnout, Professional | 1 | 2024 | 694 | 0.130 |
Why?
|
| Vascular Patency | 1 | 1998 | 887 | 0.130 |
Why?
|
| Time Factors | 8 | 2023 | 40038 | 0.130 |
Why?
|
| Oxyhemoglobins | 1 | 1996 | 216 | 0.130 |
Why?
|
| Adult | 22 | 2021 | 213889 | 0.120 |
Why?
|
| Prospective Studies | 13 | 2022 | 53250 | 0.120 |
Why?
|
| Guidelines as Topic | 1 | 2021 | 1404 | 0.120 |
Why?
|
| Outpatients | 1 | 2022 | 1488 | 0.120 |
Why?
|
| Medication Reconciliation | 1 | 2016 | 151 | 0.120 |
Why?
|
| Alloxan | 1 | 1994 | 13 | 0.120 |
Why?
|
| Patient Care | 1 | 2020 | 638 | 0.120 |
Why?
|
| Anastomosis, Surgical | 3 | 2009 | 987 | 0.120 |
Why?
|
| Synovial Cyst | 1 | 1994 | 35 | 0.120 |
Why?
|
| Tendon Injuries | 1 | 2017 | 313 | 0.120 |
Why?
|
| Information Systems | 1 | 2016 | 410 | 0.120 |
Why?
|
| Vascular Surgical Procedures | 2 | 1998 | 1476 | 0.120 |
Why?
|
| Middle Aged | 27 | 2021 | 213241 | 0.120 |
Why?
|
| Hemolysis | 1 | 1996 | 420 | 0.120 |
Why?
|
| Onium Compounds | 1 | 2013 | 31 | 0.120 |
Why?
|
| Wakefulness | 1 | 2020 | 1243 | 0.120 |
Why?
|
| Uric Acid | 1 | 1999 | 765 | 0.110 |
Why?
|
| Single-Blind Method | 2 | 2014 | 1586 | 0.110 |
Why?
|
| Monitoring, Physiologic | 1 | 2021 | 1738 | 0.110 |
Why?
|
| Dinitrochlorobenzene | 1 | 1993 | 18 | 0.110 |
Why?
|
| Soft Tissue Injuries | 1 | 1995 | 176 | 0.110 |
Why?
|
| Fascia | 1 | 2014 | 135 | 0.110 |
Why?
|
| Counseling | 1 | 2021 | 1523 | 0.110 |
Why?
|
| Wrist | 1 | 1995 | 223 | 0.110 |
Why?
|
| Quality Assurance, Health Care | 1 | 2004 | 2211 | 0.110 |
Why?
|
| Martial Arts | 1 | 1993 | 27 | 0.110 |
Why?
|
| Animals | 29 | 2013 | 168660 | 0.110 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2006 | 8300 | 0.110 |
Why?
|
| Aged | 21 | 2021 | 163178 | 0.110 |
Why?
|
| Feasibility Studies | 3 | 2017 | 5078 | 0.110 |
Why?
|
| Intracranial Arteriosclerosis | 1 | 2013 | 138 | 0.110 |
Why?
|
| Complement System Proteins | 1 | 1996 | 796 | 0.110 |
Why?
|
| Follow-Up Studies | 6 | 2022 | 39001 | 0.110 |
Why?
|
| Tibial Fractures | 1 | 1995 | 269 | 0.100 |
Why?
|
| Rats, Inbred Strains | 6 | 1991 | 2184 | 0.100 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2024 | 20121 | 0.100 |
Why?
|
| Rats, Inbred Lew | 3 | 2003 | 1162 | 0.100 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2013 | 334 | 0.100 |
Why?
|
| Thrombectomy | 1 | 2016 | 680 | 0.100 |
Why?
|
| alpha-Thalassemia | 2 | 2001 | 46 | 0.100 |
Why?
|
| Point-of-Care Systems | 1 | 2020 | 1177 | 0.100 |
Why?
|
| Fibrinolytic Agents | 2 | 2022 | 2159 | 0.100 |
Why?
|
| Cell Movement | 1 | 2003 | 5216 | 0.100 |
Why?
|
| Perioperative Period | 1 | 2012 | 256 | 0.100 |
Why?
|
| Hemoglobins | 2 | 2001 | 1531 | 0.100 |
Why?
|
| Reproducibility of Results | 3 | 2024 | 19894 | 0.090 |
Why?
|
| Laser Therapy | 1 | 1998 | 1071 | 0.090 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2016 | 782 | 0.090 |
Why?
|
| Evidence-Based Practice | 1 | 2015 | 500 | 0.090 |
Why?
|
| Intensive Care Units | 2 | 2020 | 3679 | 0.090 |
Why?
|
| Finger Joint | 1 | 2011 | 108 | 0.090 |
Why?
|
| Radiography, Thoracic | 1 | 2016 | 1265 | 0.090 |
Why?
|
| Breast | 1 | 1999 | 1970 | 0.090 |
Why?
|
| Medication Errors | 1 | 2016 | 798 | 0.090 |
Why?
|
| Leg | 1 | 1995 | 1116 | 0.090 |
Why?
|
| Nerve Transfer | 1 | 1991 | 120 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 5 | 2004 | 6170 | 0.090 |
Why?
|
| Aged, 80 and over | 10 | 2020 | 57744 | 0.090 |
Why?
|
| Emergency Medical Services | 1 | 2021 | 1917 | 0.090 |
Why?
|
| Muscles | 3 | 1991 | 1613 | 0.090 |
Why?
|
| Nitric Oxide | 1 | 1998 | 2132 | 0.090 |
Why?
|
| Respiration, Artificial | 1 | 2020 | 2568 | 0.090 |
Why?
|
| Health Behavior | 1 | 2021 | 2634 | 0.090 |
Why?
|
| Thoracic Injuries | 1 | 1992 | 272 | 0.090 |
Why?
|
| Education, Medical, Graduate | 2 | 2018 | 2291 | 0.090 |
Why?
|
| Diagnostic Imaging | 1 | 2023 | 3503 | 0.080 |
Why?
|
| Point Mutation | 2 | 2001 | 1623 | 0.080 |
Why?
|
| Myocardial Infarction | 3 | 2017 | 11708 | 0.080 |
Why?
|
| Constriction, Pathologic | 1 | 2012 | 1108 | 0.080 |
Why?
|
| Sequence Alignment | 1 | 2013 | 2256 | 0.080 |
Why?
|
| Hospitalization | 3 | 2023 | 10259 | 0.080 |
Why?
|
| Patient Participation | 1 | 2017 | 1457 | 0.080 |
Why?
|
| Embryonic Development | 1 | 2013 | 710 | 0.080 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2019 | 1462 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2013 | 1284 | 0.080 |
Why?
|
| Syndactyly | 1 | 2008 | 72 | 0.080 |
Why?
|
| Adenine | 1 | 2013 | 935 | 0.080 |
Why?
|
| Observer Variation | 1 | 2014 | 2592 | 0.080 |
Why?
|
| Heart Valve Diseases | 2 | 2014 | 1073 | 0.080 |
Why?
|
| Endophthalmitis | 1 | 2010 | 262 | 0.080 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2019 | 1458 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 2008 | 374 | 0.070 |
Why?
|
| Hand Deformities, Congenital | 1 | 2008 | 146 | 0.070 |
Why?
|
| DNA Damage | 2 | 2013 | 2429 | 0.070 |
Why?
|
| Thiobarbituric Acid Reactive Substances | 2 | 1997 | 46 | 0.070 |
Why?
|
| Lung Transplantation | 1 | 1996 | 1155 | 0.070 |
Why?
|
| Carotid Stenosis | 2 | 2013 | 854 | 0.070 |
Why?
|
| Medical Errors | 1 | 2015 | 1297 | 0.070 |
Why?
|
| Glycine | 1 | 2010 | 670 | 0.070 |
Why?
|
| Cyclic GMP-Dependent Protein Kinases | 1 | 2006 | 30 | 0.070 |
Why?
|
| Blood Pressure | 1 | 2022 | 8551 | 0.070 |
Why?
|
| Electronic Health Records | 3 | 2020 | 4467 | 0.070 |
Why?
|
| Fellowships and Scholarships | 1 | 2015 | 1077 | 0.070 |
Why?
|
| Postoperative Complications | 2 | 2019 | 15281 | 0.070 |
Why?
|
| Sciatic Neuropathy | 1 | 2006 | 74 | 0.070 |
Why?
|
| Geriatric Assessment | 1 | 2013 | 1372 | 0.070 |
Why?
|
| Suture Techniques | 2 | 1993 | 797 | 0.070 |
Why?
|
| Hydroxyl Radical | 2 | 1997 | 78 | 0.070 |
Why?
|
| Hair | 2 | 2023 | 480 | 0.070 |
Why?
|
| Orthopedics | 1 | 2015 | 904 | 0.070 |
Why?
|
| Molecular Sequence Data | 3 | 2013 | 18107 | 0.070 |
Why?
|
| Electrocardiography | 2 | 2018 | 6441 | 0.070 |
Why?
|
| Workflow | 2 | 2020 | 847 | 0.060 |
Why?
|
| Curriculum | 1 | 2018 | 3603 | 0.060 |
Why?
|
| Chronic Disease | 1 | 2020 | 9139 | 0.060 |
Why?
|
| Arm Injuries | 2 | 2000 | 160 | 0.060 |
Why?
|
| Wounds and Injuries | 1 | 2017 | 2401 | 0.060 |
Why?
|
| Acute Disease | 2 | 2010 | 7150 | 0.060 |
Why?
|
| Thoracic Nerves | 1 | 2004 | 19 | 0.060 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2014 | 2267 | 0.060 |
Why?
|
| Pain Measurement | 1 | 2014 | 3420 | 0.060 |
Why?
|
| Clinical Competence | 2 | 2018 | 4687 | 0.060 |
Why?
|
| RNA Interference | 1 | 2013 | 2890 | 0.060 |
Why?
|
| Iliac Vein | 1 | 2004 | 72 | 0.060 |
Why?
|
| Caenorhabditis elegans | 1 | 2013 | 1417 | 0.060 |
Why?
|
| Taiwan | 4 | 2001 | 497 | 0.060 |
Why?
|
| United States | 7 | 2021 | 69859 | 0.060 |
Why?
|
| Graft Rejection | 2 | 1996 | 4398 | 0.060 |
Why?
|
| RNA, Small Interfering | 1 | 2013 | 3504 | 0.060 |
Why?
|
| Neurons, Afferent | 1 | 2006 | 504 | 0.060 |
Why?
|
| Receptors, Interferon | 1 | 2004 | 115 | 0.060 |
Why?
|
| Dissection | 2 | 1999 | 294 | 0.060 |
Why?
|
| Receptor, Interferon alpha-beta | 1 | 2004 | 105 | 0.060 |
Why?
|
| Nerve Block | 1 | 1990 | 644 | 0.060 |
Why?
|
| Chromosome Deletion | 1 | 2008 | 1396 | 0.060 |
Why?
|
| Estrus | 1 | 2003 | 81 | 0.060 |
Why?
|
| Risk Factors | 7 | 2019 | 72252 | 0.060 |
Why?
|
| Transplantation, Isogeneic | 1 | 2003 | 257 | 0.060 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2014 | 2074 | 0.050 |
Why?
|
| Nociceptors | 1 | 2006 | 432 | 0.050 |
Why?
|
| Cohort Studies | 3 | 2016 | 40545 | 0.050 |
Why?
|
| Oxidation-Reduction | 3 | 1997 | 2183 | 0.050 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2013 | 2944 | 0.050 |
Why?
|
| Transplantation, Homologous | 2 | 2006 | 4777 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3134 | 0.050 |
Why?
|
| Blood Vessels | 1 | 2008 | 1124 | 0.050 |
Why?
|
| Free Radicals | 3 | 1997 | 237 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3241 | 0.050 |
Why?
|
| Ovulation | 1 | 2003 | 189 | 0.050 |
Why?
|
| Cadaver | 2 | 2017 | 1335 | 0.050 |
Why?
|
| Prostheses and Implants | 1 | 2009 | 1385 | 0.050 |
Why?
|
| Immunoenzyme Techniques | 2 | 2003 | 1799 | 0.050 |
Why?
|
| Public Health | 1 | 2015 | 2603 | 0.050 |
Why?
|
| Amniotic Fluid | 1 | 2004 | 370 | 0.050 |
Why?
|
| Reference Values | 2 | 1999 | 4974 | 0.050 |
Why?
|
| Workload | 2 | 2018 | 849 | 0.050 |
Why?
|
| Kinetics | 3 | 1996 | 6476 | 0.050 |
Why?
|
| Esthetics | 1 | 2023 | 305 | 0.050 |
Why?
|
| Microsatellite Repeats | 1 | 2004 | 799 | 0.050 |
Why?
|
| Amino Acid Sequence | 1 | 2013 | 13809 | 0.050 |
Why?
|
| Scalp | 1 | 1984 | 378 | 0.050 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2013 | 3070 | 0.050 |
Why?
|
| Abnormalities, Multiple | 1 | 2008 | 1416 | 0.050 |
Why?
|
| Diabetes Mellitus | 1 | 1999 | 5752 | 0.050 |
Why?
|
| Globins | 1 | 2001 | 416 | 0.050 |
Why?
|
| Ovariectomy | 1 | 2003 | 661 | 0.050 |
Why?
|
| Electron Spin Resonance Spectroscopy | 2 | 1997 | 165 | 0.050 |
Why?
|
| Time and Motion Studies | 1 | 2020 | 149 | 0.050 |
Why?
|
| Health Facility Environment | 1 | 2020 | 34 | 0.050 |
Why?
|
| Genetic Variation | 2 | 1996 | 6535 | 0.050 |
Why?
|
| Blotting, Southern | 1 | 2000 | 803 | 0.050 |
Why?
|
| Muscle, Skeletal | 1 | 1995 | 4925 | 0.040 |
Why?
|
| Osseointegration | 1 | 2001 | 262 | 0.040 |
Why?
|
| Nervous System Diseases | 1 | 2010 | 1619 | 0.040 |
Why?
|
| Tissue Engineering | 1 | 2009 | 1880 | 0.040 |
Why?
|
| Iduronate Sulfatase | 1 | 1999 | 11 | 0.040 |
Why?
|
| Hospital Bed Capacity | 1 | 2020 | 215 | 0.040 |
Why?
|
| Pregnancy Complications, Hematologic | 1 | 2000 | 183 | 0.040 |
Why?
|
| Femoral Artery | 2 | 1998 | 845 | 0.040 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 2001 | 287 | 0.040 |
Why?
|
| Hydroxylation | 2 | 1997 | 141 | 0.040 |
Why?
|
| Skin Neoplasms | 1 | 2017 | 5691 | 0.040 |
Why?
|
| Mercaptoethanol | 1 | 1997 | 64 | 0.040 |
Why?
|
| Salicylates | 2 | 1997 | 126 | 0.040 |
Why?
|
| Genetic Markers | 1 | 2004 | 2634 | 0.040 |
Why?
|
| Substance-Related Disorders | 1 | 2013 | 4254 | 0.040 |
Why?
|
| Prognosis | 4 | 2013 | 29052 | 0.040 |
Why?
|
| Sequence Deletion | 1 | 2001 | 1524 | 0.040 |
Why?
|
| Spectrometry, Fluorescence | 2 | 1997 | 688 | 0.040 |
Why?
|
| Deferoxamine | 1 | 1997 | 151 | 0.040 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 1998 | 534 | 0.040 |
Why?
|
| Palladium | 1 | 1997 | 63 | 0.040 |
Why?
|
| Double-Blind Method | 2 | 2010 | 12020 | 0.040 |
Why?
|
| Hemoglobin E | 1 | 1996 | 6 | 0.030 |
Why?
|
| Arteries | 2 | 1993 | 1119 | 0.030 |
Why?
|
| Monocrotaline | 1 | 1996 | 26 | 0.030 |
Why?
|
| Waiting Lists | 1 | 2020 | 692 | 0.030 |
Why?
|
| Neural Conduction | 3 | 1989 | 441 | 0.030 |
Why?
|
| Nerve Fibers | 1 | 1999 | 687 | 0.030 |
Why?
|
| Saponins | 1 | 1996 | 50 | 0.030 |
Why?
|
| Hemoglobin A | 1 | 1996 | 87 | 0.030 |
Why?
|
| Spinal Cord Injuries | 1 | 2004 | 931 | 0.030 |
Why?
|
| Hospitals, Urban | 1 | 1998 | 499 | 0.030 |
Why?
|
| Algorithms | 1 | 2016 | 13869 | 0.030 |
Why?
|
| Gene Deletion | 2 | 2000 | 2749 | 0.030 |
Why?
|
| Sutures | 1 | 1998 | 299 | 0.030 |
Why?
|
| Nitric Oxide Synthase | 1 | 1998 | 915 | 0.030 |
Why?
|
| Rabbits | 2 | 2001 | 4894 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2023 | 2307 | 0.030 |
Why?
|
| Hemoglobin, Sickle | 1 | 1996 | 122 | 0.030 |
Why?
|
| Surgical Procedures, Operative | 2 | 1999 | 1877 | 0.030 |
Why?
|
| Platinum | 1 | 1997 | 231 | 0.030 |
Why?
|
| Tibial Arteries | 1 | 1995 | 57 | 0.030 |
Why?
|
| DNA | 2 | 2004 | 7295 | 0.030 |
Why?
|
| Logistic Models | 1 | 2010 | 13404 | 0.030 |
Why?
|
| Aftercare | 1 | 2021 | 870 | 0.030 |
Why?
|
| Digoxin | 1 | 1996 | 250 | 0.030 |
Why?
|
| Incidence | 4 | 2013 | 20948 | 0.030 |
Why?
|
| Salicylic Acid | 1 | 1994 | 56 | 0.030 |
Why?
|
| Pyruvate Kinase | 1 | 1996 | 189 | 0.030 |
Why?
|
| Growth Substances | 1 | 1996 | 784 | 0.030 |
Why?
|
| Chickens | 1 | 1996 | 864 | 0.030 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 1994 | 424 | 0.030 |
Why?
|
| Documentation | 1 | 2020 | 871 | 0.030 |
Why?
|
| Rats, Inbred BN | 1 | 1993 | 235 | 0.030 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 1998 | 430 | 0.030 |
Why?
|
| Hand Injuries | 2 | 1990 | 242 | 0.030 |
Why?
|
| Immunosuppressive Agents | 1 | 2006 | 4152 | 0.030 |
Why?
|
| Cardiac Output | 1 | 1996 | 854 | 0.030 |
Why?
|
| Fetal Hemoglobin | 1 | 1996 | 341 | 0.030 |
Why?
|
| Mental Disorders | 1 | 2013 | 6593 | 0.030 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 1996 | 494 | 0.030 |
Why?
|
| Popliteal Artery | 1 | 1995 | 317 | 0.030 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2017 | 499 | 0.030 |
Why?
|
| Neural Pathways | 1 | 2004 | 2971 | 0.030 |
Why?
|
| Pulmonary Circulation | 1 | 1996 | 739 | 0.030 |
Why?
|
| Sensation | 1 | 1995 | 336 | 0.030 |
Why?
|
| Safety | 1 | 1998 | 1184 | 0.030 |
Why?
|
| Vitamin E | 1 | 1997 | 868 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2020 | 35409 | 0.030 |
Why?
|
| Vascular Resistance | 1 | 1996 | 936 | 0.030 |
Why?
|
| Infusions, Intravenous | 1 | 1998 | 2274 | 0.030 |
Why?
|
| Surface Properties | 1 | 1996 | 1168 | 0.030 |
Why?
|
| Work Schedule Tolerance | 1 | 2017 | 563 | 0.030 |
Why?
|
| Pressure | 1 | 1996 | 1205 | 0.030 |
Why?
|
| Child | 4 | 2015 | 77637 | 0.030 |
Why?
|
| Liposomes | 1 | 1996 | 759 | 0.030 |
Why?
|
| Muscle Denervation | 1 | 1991 | 57 | 0.030 |
Why?
|
| Phospholipids | 1 | 1996 | 784 | 0.030 |
Why?
|
| Wrist Joint | 1 | 1994 | 256 | 0.030 |
Why?
|
| Tibial Nerve | 1 | 1991 | 50 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 1996 | 1892 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2013 | 23327 | 0.030 |
Why?
|
| Peroneal Nerve | 1 | 1991 | 74 | 0.030 |
Why?
|
| Clinical Protocols | 1 | 1998 | 1459 | 0.030 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 1994 | 473 | 0.030 |
Why?
|
| Sural Nerve | 1 | 1991 | 106 | 0.030 |
Why?
|
| Diet, Reducing | 1 | 2015 | 462 | 0.030 |
Why?
|
| Genetic Testing | 2 | 2001 | 3439 | 0.030 |
Why?
|
| Neoplasms | 1 | 2020 | 21675 | 0.020 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2004 | 2018 | 0.020 |
Why?
|
| Contrast Media | 2 | 2020 | 5301 | 0.020 |
Why?
|
| Asia, Southeastern | 2 | 2001 | 111 | 0.020 |
Why?
|
| Temperature | 1 | 1998 | 2202 | 0.020 |
Why?
|
| Cold Temperature | 1 | 1995 | 771 | 0.020 |
Why?
|
| Base Sequence | 2 | 1993 | 12798 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 1998 | 2217 | 0.020 |
Why?
|
| Postoperative Care | 1 | 2017 | 1485 | 0.020 |
Why?
|
| Enzyme Inhibitors | 2 | 2006 | 3794 | 0.020 |
Why?
|
| Cerebrovascular Disorders | 1 | 1998 | 1504 | 0.020 |
Why?
|
| Scapula | 1 | 1992 | 164 | 0.020 |
Why?
|
| Thigh | 1 | 1991 | 247 | 0.020 |
Why?
|
| Pandemics | 2 | 2020 | 8385 | 0.020 |
Why?
|
| Injections, Intradermal | 1 | 1990 | 117 | 0.020 |
Why?
|
| Brachial Plexus | 1 | 1992 | 163 | 0.020 |
Why?
|
| Ear Cartilage | 1 | 1990 | 62 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1993 | 1800 | 0.020 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1991 | 708 | 0.020 |
Why?
|
| Clavicle | 1 | 1992 | 209 | 0.020 |
Why?
|
| Reoperation | 1 | 1999 | 4200 | 0.020 |
Why?
|
| Hospitals | 1 | 2023 | 3953 | 0.020 |
Why?
|
| Cattle | 1 | 1996 | 3917 | 0.020 |
Why?
|
| Continuity of Patient Care | 1 | 2017 | 1049 | 0.020 |
Why?
|
| Wound Healing | 1 | 2001 | 2776 | 0.020 |
Why?
|
| Metacarpophalangeal Joint | 1 | 1990 | 82 | 0.020 |
Why?
|
| Abdominal Muscles | 1 | 1990 | 166 | 0.020 |
Why?
|
| Muscular Diseases | 1 | 1994 | 555 | 0.020 |
Why?
|
| Cartilage | 1 | 1993 | 818 | 0.020 |
Why?
|
| Behavior Therapy | 1 | 2015 | 862 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2022 | 3530 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2021 | 9848 | 0.020 |
Why?
|
| Nerve Tissue | 1 | 1989 | 79 | 0.020 |
Why?
|
| Electrophysiology | 1 | 1991 | 1297 | 0.020 |
Why?
|
| Program Development | 1 | 2015 | 1314 | 0.020 |
Why?
|
| Neurosurgical Procedures | 1 | 1999 | 2002 | 0.020 |
Why?
|
| Potassium | 1 | 1993 | 1336 | 0.020 |
Why?
|
| Activities of Daily Living | 1 | 1998 | 2419 | 0.020 |
Why?
|
| Boston | 1 | 2021 | 9310 | 0.020 |
Why?
|
| Mass Screening | 1 | 2004 | 5251 | 0.020 |
Why?
|
| Ticlopidine | 1 | 2013 | 899 | 0.020 |
Why?
|
| Ischemic Attack, Transient | 1 | 2013 | 934 | 0.020 |
Why?
|
| Fungi | 1 | 2010 | 326 | 0.020 |
Why?
|
| Morbidity | 1 | 2013 | 1768 | 0.020 |
Why?
|
| Patient Satisfaction | 1 | 2020 | 3391 | 0.020 |
Why?
|
| Eye Infections, Bacterial | 1 | 2010 | 235 | 0.020 |
Why?
|
| Disease Models, Animal | 3 | 2004 | 18027 | 0.020 |
Why?
|
| Vitrectomy | 1 | 2010 | 365 | 0.020 |
Why?
|
| Australia | 1 | 2010 | 1167 | 0.020 |
Why?
|
| Cause of Death | 1 | 1998 | 3580 | 0.020 |
Why?
|
| Secondary Prevention | 1 | 2013 | 1529 | 0.020 |
Why?
|
| Mice | 2 | 2013 | 81154 | 0.020 |
Why?
|
| History, 21st Century | 1 | 2013 | 1532 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2004 | 8939 | 0.020 |
Why?
|
| Thionucleotides | 1 | 2006 | 107 | 0.020 |
Why?
|
| Prevalence | 2 | 2013 | 15211 | 0.020 |
Why?
|
| Inflammation | 1 | 2006 | 10629 | 0.020 |
Why?
|
| Freund's Adjuvant | 1 | 2006 | 139 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2020 | 7784 | 0.020 |
Why?
|
| Fibrosis | 1 | 1993 | 2030 | 0.020 |
Why?
|
| Young Adult | 3 | 2020 | 56392 | 0.020 |
Why?
|
| Nerve Growth Factors | 1 | 1989 | 574 | 0.020 |
Why?
|
| Pain | 2 | 1999 | 4987 | 0.020 |
Why?
|
| Exons | 1 | 1991 | 2438 | 0.020 |
Why?
|
| S100 Proteins | 1 | 2006 | 259 | 0.020 |
Why?
|
| Iothalamic Acid | 1 | 1985 | 18 | 0.020 |
Why?
|
| Angiocardiography | 1 | 1985 | 162 | 0.020 |
Why?
|
| Motivation | 1 | 2015 | 1971 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2001 | 9239 | 0.020 |
Why?
|
| Age Factors | 2 | 2013 | 18355 | 0.020 |
Why?
|
| Hypertension, Pulmonary | 1 | 1996 | 1534 | 0.020 |
Why?
|
| Cyclic GMP | 1 | 2006 | 408 | 0.020 |
Why?
|
| History, 20th Century | 1 | 2013 | 2736 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2015 | 2760 | 0.020 |
Why?
|
| TRPV Cation Channels | 1 | 2006 | 237 | 0.020 |
Why?
|
| Pregnancy | 2 | 2004 | 29140 | 0.020 |
Why?
|
| Inpatients | 1 | 2016 | 2515 | 0.020 |
Why?
|
| Heart Rate | 1 | 1996 | 4091 | 0.020 |
Why?
|
| Cholinergic Fibers | 1 | 2004 | 68 | 0.020 |
Why?
|
| Neurofilament Proteins | 1 | 2006 | 318 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2016 | 8637 | 0.010 |
Why?
|
| Telemedicine | 1 | 2021 | 2874 | 0.010 |
Why?
|
| Ganglia, Spinal | 1 | 2006 | 519 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 15526 | 0.010 |
Why?
|
| Tissue Donors | 1 | 1993 | 2241 | 0.010 |
Why?
|
| Communication | 1 | 2017 | 3748 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 1996 | 5388 | 0.010 |
Why?
|
| Feeding Behavior | 1 | 2015 | 3187 | 0.010 |
Why?
|
| Calcium | 1 | 1996 | 5755 | 0.010 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 1994 | 2217 | 0.010 |
Why?
|
| Telomere | 1 | 2008 | 910 | 0.010 |
Why?
|
| Hindlimb | 1 | 2004 | 503 | 0.010 |
Why?
|
| Cell Count | 1 | 2006 | 1855 | 0.010 |
Why?
|
| Leg Ulcer | 1 | 1982 | 69 | 0.010 |
Why?
|
| Visual Acuity | 1 | 2010 | 2525 | 0.010 |
Why?
|
| Aspirin | 1 | 2013 | 3283 | 0.010 |
Why?
|
| Hospital Mortality | 1 | 2015 | 5316 | 0.010 |
Why?
|
| Digoxigenin | 1 | 2000 | 26 | 0.010 |
Why?
|
| Chorionic Villi Sampling | 1 | 2000 | 32 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2016 | 7729 | 0.010 |
Why?
|
| Oxygen | 1 | 1993 | 4189 | 0.010 |
Why?
|
| Erythrocyte Count | 1 | 2001 | 163 | 0.010 |
Why?
|
| Education, Medical | 1 | 2013 | 1722 | 0.010 |
Why?
|
| Action Potentials | 1 | 1988 | 1804 | 0.010 |
Why?
|
| Recurrence | 1 | 2012 | 8337 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 2004 | 1137 | 0.010 |
Why?
|
| Protein Transport | 1 | 2006 | 1988 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2006 | 3701 | 0.010 |
Why?
|
| Fractures, Bone | 1 | 1992 | 1946 | 0.010 |
Why?
|
| Bacteria | 1 | 2010 | 2112 | 0.010 |
Why?
|
| Survival Rate | 1 | 2013 | 12786 | 0.010 |
Why?
|
| Mucopolysaccharidosis II | 1 | 1999 | 27 | 0.010 |
Why?
|
| Motor Neurons | 1 | 2004 | 841 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 2004 | 1760 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2012 | 12243 | 0.010 |
Why?
|
| Exercise | 1 | 2015 | 5611 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 1994 | 12954 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2006 | 5179 | 0.010 |
Why?
|
| Multigene Family | 1 | 2001 | 1101 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 1994 | 11478 | 0.010 |
Why?
|
| Radiography | 1 | 2008 | 7010 | 0.010 |
Why?
|
| Muscle Development | 1 | 1979 | 272 | 0.010 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 1997 | 211 | 0.010 |
Why?
|
| DNA, Superhelical | 1 | 1997 | 50 | 0.010 |
Why?
|
| Spectrophotometry | 1 | 1997 | 313 | 0.010 |
Why?
|
| Facial Nerve | 1 | 1979 | 271 | 0.010 |
Why?
|
| Cardenolides | 1 | 1996 | 20 | 0.010 |
Why?
|
| Isoelectric Point | 1 | 1996 | 79 | 0.010 |
Why?
|
| Vagus Nerve | 1 | 1979 | 439 | 0.010 |
Why?
|
| Adolescent | 2 | 2016 | 85729 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2010 | 12354 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 1993 | 7880 | 0.010 |
Why?
|
| Spinal Cord | 1 | 2004 | 1809 | 0.010 |
Why?
|
| Heterozygote | 1 | 2001 | 2803 | 0.010 |
Why?
|
| Fracture Fixation, Internal | 1 | 1981 | 917 | 0.010 |
Why?
|
| Cycloheximide | 1 | 1994 | 347 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1996 | 2253 | 0.010 |
Why?
|
| Signal Transduction | 1 | 1996 | 23398 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2006 | 11360 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 1994 | 1102 | 0.010 |
Why?
|
| Heart Failure | 1 | 2016 | 10896 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1996 | 1574 | 0.010 |
Why?
|
| Plasmids | 1 | 1997 | 2308 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 1999 | 4749 | 0.010 |
Why?
|
| Epidermal Growth Factor | 1 | 1994 | 709 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2001 | 4848 | 0.010 |
Why?
|
| Alleles | 1 | 2001 | 6934 | 0.010 |
Why?
|
| Coronary Disease | 1 | 1985 | 6078 | 0.010 |
Why?
|
| Isoenzymes | 1 | 1994 | 1728 | 0.010 |
Why?
|
| Mutation, Missense | 1 | 1999 | 2566 | 0.010 |
Why?
|
| Brain | 1 | 1996 | 26345 | 0.010 |
Why?
|
| Iron | 1 | 1997 | 1774 | 0.000 |
Why?
|
| Multiple Trauma | 1 | 1990 | 367 | 0.000 |
Why?
|
| Sequence Analysis, DNA | 1 | 1999 | 4803 | 0.000 |
Why?
|
| Tumor Cells, Cultured | 1 | 1994 | 6311 | 0.000 |
Why?
|
| Infant | 1 | 2008 | 35122 | 0.000 |
Why?
|
| Swine | 1 | 1996 | 5909 | 0.000 |
Why?
|
| Diatrizoate | 1 | 1985 | 86 | 0.000 |
Why?
|
| Diatrizoate Meglumine | 1 | 1985 | 83 | 0.000 |
Why?
|
| Iopamidol | 1 | 1985 | 191 | 0.000 |
Why?
|
| Genotype | 1 | 1999 | 12944 | 0.000 |
Why?
|
| RNA, Messenger | 1 | 1999 | 13028 | 0.000 |
Why?
|
| Fibroblast Growth Factors | 1 | 1989 | 878 | 0.000 |
Why?
|
| Thorax | 1 | 1985 | 547 | 0.000 |
Why?
|
| Phenotype | 1 | 1999 | 16361 | 0.000 |
Why?
|
| Random Allocation | 1 | 1985 | 2429 | 0.000 |
Why?
|
| Drug Combinations | 1 | 1985 | 1958 | 0.000 |
Why?
|
| Cell Line | 1 | 1994 | 15993 | 0.000 |
Why?
|
| Cerebral Cortex | 1 | 1996 | 5692 | 0.000 |
Why?
|
| Bone Screws | 1 | 1981 | 520 | 0.000 |
Why?
|
| Hemodynamics | 1 | 1985 | 4197 | 0.000 |
Why?
|
| Clinical Trials as Topic | 1 | 1985 | 7908 | 0.000 |
Why?
|